Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Colhoun, H. M.
Right arrow Articles by Van Tol, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Colhoun, H. M.
Right arrow Articles by Van Tol, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes 50:652-659, 2001
© 2001 by the American Diabetes Association, Inc.

Lipid Transfer Protein Activities in Type 1 Diabetic Patients Without Renal Failure and Nondiabetic Control Subjects and Their Association With Coronary Artery Calcification

Helen M. Colhoun1, Leo M. Scheek2, Michael B. Rubens3, Teus Van Gent2, S. Richard Underwood3, John H. Fuller1, and Arie Van Tol2

1 Royal Free and University College London Medical School, London, U.K.
2 Department of Biochemistry, Cardiovascular Research Institute COEUR, Erasmus University, Rotterdam, the Netherlands
3 Royal Brompton and Harefield National Health Service Hospital Trust, London, U.K.

This study examined the role of cholesteryl ester transfer (CET), cholesteryl ester transfer protein (CETP) activity, and phospholipid transfer protein (PLTP) activity in the increased prevalence of coronary artery calcification (CAC) in diabetic subjects compared with nondiabetic subjects and in the loss of the sex difference in CAC in diabetes. CETP activity, PLTP activity, and CET were measured in 195 type 1 diabetic subjects without renal failure and 194 nondiabetic control subjects of similar age (30–55 years) and sex distribution (50% female). CAC was quantified with electron beam computed tomography. CETP activity was higher in diabetic subjects (mean 84 arbitrary units [AU]) than in nondiabetic subjects (80 AU, P = 0.028). PLTP activity was also higher in diabetic subjects (96 AU) than in nondiabetic subjects (81 AU, P < 0.001). However, CET was lower in diabetic men (geometric mean 32 nmol · ml–1 · h–1) than nondiabetic men (37 nmol · ml–1 · h–1, P = 0.004) and did not differ between diabetic (30 nmol · ml–1 · h–1) and nondiabetic (32 nmol · ml–1 · h–1, P = 0.3) women. CETP and PLTP activities were not associated with CAC. CET was positively associated with CAC in both diabetic and nondiabetic subjects (odds ratio per 10 nmol · ml–1 · h–1 increase in CET in all subjects = 1.4, P = 0.001). The prevalence of CAC was similar in diabetic (51%) and nondiabetic (54%, P = 0.7) men but was much higher in diabetic (47%) than nondiabetic (21%, odds ratio 3.6, P < 0.001) women so that there was no sex difference in CAC in diabetic subjects. The odds of CAC in diabetic women compared with nondiabetic women was altered little by adjustment for CETP activity, PLTP activity, or CET (odds ratio on adjustment 3.7, P < 0.001). The greater effect of diabetes on CAC in women than in men, i.e., the loss of the sex difference in CAC, was independent of CETP and PLTP activity and CET. In conclusion, among both diabetic and nondiabetic subjects, higher cholesteryl ester transfer is a risk factor for CAC. However, abnormalities in cholesteryl ester transfer or lipid transfer protein activities do not underlie the increased CAC risk in diabetic women compared with nondiabetic women or the loss of the sex difference in CAC in diabetes.


Abbreviations: AU, arbitrary units; CAC, coronary artery calcification; CET, cholesteryl ester transfer; CETP, CET protein; CHD, coronary heart disease; CV, coefficient of variation; HDL-C, HDL cholesterol; LDL-C, LDL cholesterol; PLTP, phospholipid transfer protein


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
S. E. Borggreve, H. L. Hillege, G. M. Dallinga-Thie, P. E. de Jong, B. H.R. Wolffenbuttel, D. E. Grobbee, A. van Tol, R. P.F. Dullaart, and on behalf of the PREVEND Study Group
High plasma cholesteryl ester transfer protein levels may favour reduced incidence of cardiovascular events in men with low triglycerides
Eur. Heart J., April 4, 2007; (2007) ehm062v1.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
D. R. Witte, M. R. Taskinen, H. Perttunen-Nio, A. van Tol, S. Livingstone, and H. M. Colhoun
Study of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresis
J. Lipid Res., June 1, 2004; 45(6): 1069 - 1076.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
D. Dabelea, G. Kinney, J. K. Snell-Bergeon, J. E. Hokanson, R. H. Eckel, J. Ehrlich, S. Garg, R. F. Hamman, and M. Rewers
Effect of Type 1 Diabetes on the Gender Difference in Coronary Artery Calcification: a Role for Insulin Resistance?: The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study
Diabetes, November 1, 2003; 52(11): 2833 - 2839.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. J. Murdoch, S. E. Kahn, J. J. Albers, J. D. Brunzell, and J. Q. Purnell
PLTP activity decreases with weight loss: changes in PLTP are associated with changes in subcutaneous fat and FFA but not IAF or insulin sensitivity
J. Lipid Res., September 1, 2003; 44(9): 1705 - 1712.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. van Haperen, A. van Tol, T. van Gent, L. Scheek, P. Visser, A. van der Kamp, F. Grosveld, and R. de Crom
Increased Risk of Atherosclerosis by Elevated Plasma Levels of Phospholipid Transfer Protein
J. Biol. Chem., December 6, 2002; 277(50): 48938 - 48943.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. Lie, R. de Crom, T. van Gent, R. van Haperen, L. Scheek, I. Lankhuizen, and A. van Tol
Elevation of plasma phospholipid transfer protein in transgenic mice increases VLDL secretion
J. Lipid Res., November 1, 2002; 43(11): 1875 - 1880.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. M. Colhoun, M.-R. Taskinen, J. D. Otvos, P. van den Berg, J. O'Connor, and A. Van Tol
Relationship of Phospholipid Transfer Protein Activity to HDL and Apolipoprotein B-Containing Lipoproteins in Subjects With and Without Type 1 Diabetes
Diabetes, November 1, 2002; 51(11): 3300 - 3305.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. M. Colhoun, J. D. Otvos, M. B. Rubens, M. R. Taskinen, S. R. Underwood, and J. H. Fuller
Lipoprotein Subclasses and Particle Sizes and Their Relationship With Coronary Artery Calcification in Men and Women With and Without Type 1 Diabetes
Diabetes, June 1, 2002; 51(6): 1949 - 1956.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2001 by the American Diabetes Association.